SKI Market

A+| A| A-|

Indian Indices

Sensex

71,947.55 -1,635.67
( -2.22%)

Global Indices

Nasdaq

45,242.12 54.47
(0.12%)

Dow Jones

6,365.58 -24.27
(-0.38%)

Hang Seng

51,747.70 -1,625.37
(-3.05%)

Nikkei 225

10,127.96 160.61
(1.61%)

Forex

USD-INR

94.53 0.44
(0.47%)

EUR-INR

108.77 0.13
(0.12%)

GBP-INR

125.32 -0.25
(-0.20%)

JPY-INR

0.59 0.00
(-0.02%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Biogen Pharmachem Industries Ltd

Industry : Finance & Investments

BSE Code

ISIN Demat

Book Value()

531752

INE703D01023

1.0977251

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

46.03

EPS(TTM)

Face Value()

Div & Yield %

0.03

Back

Biogen Pharmachem Industries reports standalone net loss of Rs 0.49 crore in the September 2025 quarter

Nov 07,2025

Net Loss of Biogen Pharmachem Industries reported to Rs 0.49 crore in the quarter ended September 2025 as against net loss of Rs 1.00 crore during the previous quarter ended September 2024. There were no Sales reported in the quarter ended September 2025 and during the previous quarter ended September 2024.

71,947.55 -1,635.67 ( -2.22%)

45,242.12 54.47 (0.12%)

6,365.58 -24.27 (-0.38%)

51,747.70 -1,625.37 (-3.05%)

10,127.96 160.61 (1.61%)

94.53 0.44 (0.47%)

108.77 0.13 (0.12%)

125.32 -0.25 (-0.20%)

0.59 0.00 (-0.02%)